← All organizations

MerLion Pharmaceuticals GmbH

For profitWebsite ↗

Also known as: MerLion Pharms Gmbh | MERLION PHARMS GMBH

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

First marketed drug

Last known activity

Dec 1, 2012

Timeline

2000s

Jun 1, 2002
MerLion Pharmaceuticals GmbH— Founded

2010s

Dec 17, 2014
finafloxacin— NDA Secondary Org

Drugs by trial phase (5 distinct, 8 trials)

Phase 2 (4 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

friulimicin b

Indications

Studied for

Marketed drugs (1)

finafloxacin

Recent trials (8)

NCT01928433Lead sponsorPhase 2Dec 1, 2012
NCT01907867Lead sponsorPhase 1Jan 1, 2012
NCT01910883Lead sponsorPhase 1Sep 1, 2010
NCT01904162Lead sponsorPhase 1Feb 1, 2010
NCT00722735Lead sponsorPhase 2Oct 1, 2008
NCT00723502Lead sponsorPhase 2Sep 1, 2008
NCT00483158Lead sponsorPhase 1Aug 1, 2007
NCT00492271Lead sponsorPhase 1Jun 1, 2007

Details

Founded: Singapore, SG Jun 1, 2002
Last known activity: Dec 1, 2012